FDA
-
-
-
-
-
-
-
BTIG Reiterates Buy Rating on Simulations Plus (SLP)
-
-
-
-
-
-
-
Simulations Plus Supported Development of Majority of FDA-Approved Drugs in 2024
-
-
-
-
-
-
-
Simulations Plus (SLP) Announces FDA Renewed DILIsym Software Licenses for 7th Year
-
-
-
-
-
-
-
ISoP New Board of Trustees Members Announced
-
-
-
-
-
-
-
Simulations Plus Receives U.S. FDA Renewal for DILIsym Software Licenses
-
-
-
-
-
-
-
DILIsym Software Publication Outlines Impact on the CGRP Field for Migraine
-
-
-
-
-
-
-
Simulations Plus Releases RENAsym® Version 1A Software for Kidney Injury
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

